Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Boehringer Ingelheim Limited
Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone: +44 (0)1344 424 600
Fax: +44 (0)1344 741 298
WWW: http://www.boehringer-ingelheim.co.uk
Medical Information Direct Line: +44 (0)1344 741 286
Medical Information e-mail: medinfo@bra.boehringer-ingelheim.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 21/09/2011
PIL Aptivus 250mg Soft Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to drug interactions
Updated on 22/10/2010 and displayed until 21/09/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to MA holder contact details
Updated on 17/12/2009 and displayed until 22/10/2010
Reasons for adding or updating:
  • Change to instructions about missed dose
  • Change to drug interactions
Updated on 24/07/2009 and displayed until 17/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
  • Changes to therapeutic indications
Updated on 07/05/2009 and displayed until 24/07/2009
Reasons for adding or updating:
  • Change to drug interactions
Updated on 20/08/2008 and displayed until 07/05/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Improved Electronic Presentation
  • Change to Further Information section
  • Change of contra-indications
  • Change to drug interactions
  • Improved Electronic Presentation
  • Change to Further Information section
  • Change to date of revision
Updated on 28/11/2007 and displayed until 20/08/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 08/06/2007 and displayed until 28/11/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 21/03/2007 and displayed until 08/06/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 09/08/2006 and displayed until 21/03/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/05/2006 and displayed until 09/08/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  tipranavir